SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-035979
Filing Date
2023-02-13
Accepted
2023-02-13 16:49:56
Documents
1
Group Members
ANNE-MARI PASTEROMEGA FUND IV GP MANAGER, LTD.OMEGA FUND IV GP, L.P.OTELLO STAMPACCHIA

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d442637dsc13ga.htm SC 13G/A 115063
  Complete submission text file 0001193125-23-035979.txt   116662
Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund IV, L.P. (Filed by) CIK: 0001528382 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Subject) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-90574 | Film No.: 23619371
SIC: 2836 Biological Products, (No Diagnostic Substances)